Page last updated: 2024-12-10

ly 368975

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thionisoxetine: norepinephrine inhibitor; an analog of nisoxetine; (R)-enantionmer is significantly more potent than (S)-enantiomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3081925
SCHEMBL ID5553626
MeSH IDM0246620

Synonyms (17)

Synonym
3-ortho-thiomethylphenoxy-n-methyl-3-phenylpropylamine
25z4p2982k ,
unii-25z4p2982k
ly 368975
benzenepropanamine, n-methyl-gamma-(2-(methylthio)phenoxy)-
ly368975
(s)-thionisoxetine
155273-01-1
thionisoxetine
n-methyl-3-(2-methylsulfanylphenoxy)-3-phenylpropan-1-amine
SCHEMBL5553626
ly-368975, (+/-)-
benzenepropanamine, n-methyl-.gamma.-(2-(methylthio)phenoxy)-
n-methyl-3-[2-(methylsulfanyl)phenoxy]-3-phenylpropan-1-amine
DTXSID90935175
Q27254014
thiotomoxetine

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"Free feeding rats given supplementary 1 h access per day to a palatable dessert test meal were tested for the anorectic effect of dehydroepiandrosterone alone or in combination with either the serotonin releasing agent dexfenfluramine or the norepinephrine uptake inhibitor thionisoxetine (LY 368975)."( Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine.
Marshall, M; Robertson, K; Rowland, NE, 2001
)
0.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]